or Try an Advanced Search...

    Technical Analysis for NOX - Noxopharm Ltd  

    Grade Last Price % Change Price Change
    F 0.060 0.00% 0.000
    NOX closed unchanged on Friday, April 19, 2024, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical NOX trend table...
    Date Alert Name Type % Chg
    Bollinger Band Squeeze Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Doji - Bullish? Reversal 0.00%
    Oversold Stochastic Weakness 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Fell Below 20 DMA Bearish -5.51%
    Older End-of-Day Signals for NOX ...

       Recent Intraday Alerts

    Alert Time
    Up 2% about 20 hours ago
    Up 1% about 20 hours ago
    Up 3% about 20 hours ago
    Possible Inside Day 1 day ago
    Possible NR7 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    NOX Chart by TradingView
    Basic chart:

    Profile

    Noxopharm Limited is a drug development company. The Company is engaged in the research and development of NOX66 in the field of adjuvant therapy in chemotherapy and radiotherapy. The Company focuses on developing a drug to treat cancer. The Company has a primary focus on the development of drugs to treat the problem of drug- and radio-resistance in cancer cells. The Company's drug NOX66 is a dosage formulation developed to protect idronoxil from being inactivated in the human body by Phase II metabolism. Its purpose is to ensure that idronoxil administered remains in an active form. The Company has its offices in Melbourne and Sydney.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Health Medicine Occupational Safety And Health Cancer Radio Drugs Clinical Medicine Resistance Therapy Drug Development Oncology Chemotherapy Radiation Therapy Cancer Treatments

    Is NOX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.165
    52 Week Low 0.033
    Average Volume 203,869
    200-Day Moving Average 0.069
    50-Day Moving Average 0.068
    20-Day Moving Average 0.065
    10-Day Moving Average 0.064
    Average True Range 0.005
    RSI (14) 42.86
    ADX 10.01
    +DI 21.650
    -DI 19.735
    Chandelier Exit (Long, 3 ATRs) 0.059
    Chandelier Exit (Short, 3 ATRs) 0.075
    Upper Bollinger Bands 0.073
    Lower Bollinger Band 0.058
    Percent B (%b) 0.15
    BandWidth 23.853
    MACD Line -0.002
    MACD Signal Line -0.002
    MACD Histogram -0.0005
    Fundamentals Value
    Market Cap 12.83 Million
    Num Shares 214 Million
    EPS -0.09
    Price-to-Earnings (P/E) Ratio -0.65
    Price-to-Sales 0.00
    Price-to-Book 10.63
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.063
    Resistance 3 (R3) 0.063 0.063 0.063
    Resistance 2 (R2) 0.063 0.062 0.063 0.062
    Resistance 1 (R1) 0.061 0.061 0.061 0.061 0.062
    Pivot Point 0.061 0.061 0.061 0.061 0.061
    Support 1 (S1) 0.059 0.060 0.059 0.059 0.058
    Support 2 (S2) 0.059 0.059 0.059 0.058
    Support 3 (S3) 0.057 0.059 0.058
    Support 4 (S4) 0.057